Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Declare:
A examine discovered that individuals who add salt to their meals have been 40% extra prone to develop sure abdomen cancers.
Ranking:
Context
A...
Sino Biopharmaceutical (HK:1177) has launched an replace.
Sino Biopharmaceutical Restricted has introduced the profitable completion of part III scientific trials for its revolutionary drug...
